COVID-19 in Lymphangioleiomyomatosis: An International Study of Outcomes and Impact of Mechanistic Target of Rapamycin Inhibition
Articolo
Data di Pubblicazione:
2022
Citazione:
COVID-19 in Lymphangioleiomyomatosis: An International Study of Outcomes and Impact of Mechanistic Target of Rapamycin Inhibition / B.G. Baldi, E. Radzikowska, V. Cottin, D.F. Dilling, A. Ataya, C.R.R. Carvalho, S. Harari, M. Koslow, J.C. Grutters, Y. Inoue, N. Gupta, S.R. Johnson. - In: CHEST. - ISSN 0012-3692. - 161:6(2022 Jun), pp. 1589-1593. [10.1016/j.chest.2021.12.640]
Tipologia IRIS:
01 - Articolo su periodico
Elenco autori:
B.G. Baldi, E. Radzikowska, V. Cottin, D.F. Dilling, A. Ataya, C.R.R. Carvalho, S. Harari, M. Koslow, J.C. Grutters, Y. Inoue, N. Gupta, S.R. Johnson
Link alla scheda completa: